In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...
University of Wisconsin-Madison Professor Zachary Morris discusses his research into the field of theranostics and the “team ...
Sanofi (SNY) stock and Insmed (INSM) stock are in focus as new treatments from the companies win backing from an expert panel ...
1dOpinion
The New Quiet Luxury? Actual Quiet
Why wellness travelers are seeking the healing power of silence—and a selection of the best destinations for true peace and ...
But using too many strong, proven ingredients at once can lead to a variety of not-so-pleasant side effects such as redness, ...
LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- How Big Is The Targeted Alpha-Therapy Market In 2025? The market for targeted alpha-therapy has seen a significant surge ...
Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital. The system is specifically designed for the clinical ...
Rogue planet Cha 1107-7626 is swallowing gas and dust at roughly six billion tons each second, the fastest planetary growth ...
Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...
What advantages are there to using remote afterloading devices, compared with manual brachytherapy procedures? Foremost, staff will be less exposed to radiation. When circumstances allow remote ...
Radiopharmaceuticals have rapidly evolved from a specialised therapeutic niche into a cornerstone of modern oncology. By ...
ATNM-400 is advancing as a first-in-class, multi-tumor Actinium-225 radiotherapy candidate with activity across prostate and lung cancers, two of the largest cancer indications globally New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback